WHITNEY MYERS: Open Payments
NPI 1962744508 · SOUTH BOSTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 107 payments from 18 companies in 2025. Trend: 2023 $1,316 · 2024 $2,082 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $436 |
| ABBVIE INC. | 25 | $315 |
| Ardelyx, Inc. | 9 | $158 |
| Regeneron Healthcare Solutions, Inc. | 11 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $137 |
| QOL Medical, LLC | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 8 | $76 |
| PFIZER INC. | 3 | $68 |
| Madrigal Pharmaceuticals | 2 | $42 |
| Novo Nordisk Inc | 2 | $36 |
Products named: TREMFYA, IBSRELA, DUPIXENT, ENTYVIO, CREON, Sucraid, VOQUEZNA, LINZESS.
Industry payments across VA — which companies pay providers there.
